138 related articles for article (PubMed ID: 37474083)
1. Tumor acidity-activatable macromolecule autophagy inhibitor and immune checkpoint blockade for robust treatment of prostate cancer.
Wang Y; Lei H; Yan B; Zhang S; Xu B; Lin M; Shuai X; Huang J; Pang J
Acta Biomater; 2023 Sep; 168():593-605. PubMed ID: 37474083
[TBL] [Abstract][Full Text] [Related]
2. Nanodrug modified with engineered cell membrane targets CDKs to activate aPD-L1 immunotherapy against liver metastasis of immune-desert colon cancer.
Ding D; Liang R; Li T; Lan T; Li Y; Huang S; He G; Ren J; Li W; Zheng Z; Chen T; Fang J; Huang L; Shuai X; Wei B
J Control Release; 2024 Apr; 369():309-324. PubMed ID: 38554771
[TBL] [Abstract][Full Text] [Related]
3. Targeted Ultrasound Nanobubbles Therapy for Prostate Cancer via Immuno-Sonodynamic Effect.
Huang X; Chen Y; Zhong F; Gui B; Hu Y; Guo Y; Deng Q; Zhou Q
Int J Nanomedicine; 2024; 19():2793-2806. PubMed ID: 38525011
[TBL] [Abstract][Full Text] [Related]
4. Lymph node targeting strategy using a hydrogel sustained-release system to load effector memory T cells improves the anti-tumor efficacy of anti-PD-1.
Cui H; Zhao YY; Han YH; Lan Z; Zou KL; Cheng GW; Chen H; Zhong PL; Chen Y; Ma LM; Chen TK; Yu GT
Acta Biomater; 2024 May; 180():423-435. PubMed ID: 38641183
[TBL] [Abstract][Full Text] [Related]
5. Moving toward improved immune checkpoint immunotherapy for advanced prostate cancer.
De Velasco MA; Kura Y; Fujita K; Uemura H
Int J Urol; 2024 Apr; 31(4):307-324. PubMed ID: 38167824
[TBL] [Abstract][Full Text] [Related]
6. Photo-induced crosslinked and anti-PD-L1 peptide incorporated liposomes to promote PD-L1 multivalent binding for effective immune checkpoint blockade therapy.
Lee Y; Song S; Yang S; Kim J; Moon Y; Shim N; Yoon HY; Kim S; Shim MK; Kim K
Acta Pharm Sin B; 2024 Mar; 14(3):1428-1440. PubMed ID: 38487005
[TBL] [Abstract][Full Text] [Related]
7. Nanodrug-bacteria conjugates-mediated oncogenic collagen depletion enhances immune checkpoint blockade therapy against pancreatic cancer.
Li Z; Mo F; Guo K; Ren S; Wang Y; Chen Y; Schwartz PB; Richmond N; Liu F; Ronnekleiv-Kelly SM; Hu Q
Med; 2024 Apr; 5(4):348-367.e7. PubMed ID: 38521069
[TBL] [Abstract][Full Text] [Related]
8. Autophagy-Inducing MoO3-x Nanowires Boost Photothermal-Triggered Cancer Immunotherapy.
He L; Chen Q; Lu Q; Yang M; Xie B; Chen T; Wang X
Angew Chem Int Ed Engl; 2024 Apr; ():e202404822. PubMed ID: 38687056
[TBL] [Abstract][Full Text] [Related]
9. A Redox-Triggered Autophagy-Induced Nanoplatform with PD-L1 Inhibition for Enhancing Combined Chemo-Immunotherapy.
Li M; Zhao D; Yan J; Fu X; Li F; Liu G; Fan Y; Liang Y; Zhang X
ACS Nano; 2024 May; ():. PubMed ID: 38727063
[TBL] [Abstract][Full Text] [Related]
10. Tumor microenvironment reprogramming combined with immunogenic enhancement by nanoemulsions potentiates immunotherapy.
Shen W; Li Y; Yang Z; Li W; Cao Y; Liu Y; Wang Z; Pei R; Xing C
J Nanobiotechnology; 2024 Apr; 22(1):154. PubMed ID: 38581017
[TBL] [Abstract][Full Text] [Related]
11. A lipid/PLGA nanocomplex to reshape tumor immune microenvironment for colon cancer therapy.
Zhang N; Sun Q; Li J; Li J; Tang L; Zhao Q; Pu Y; Liang G; He B; Gao W; Chen J
Regen Biomater; 2024; 11():rbae036. PubMed ID: 38628547
[TBL] [Abstract][Full Text] [Related]
12. Advancing cancer immunotherapy through siRNA-based gene silencing for immune checkpoint blockade.
Choi Y; Seok SH; Yoon HY; Ryu JH; Kwon IC
Adv Drug Deliv Rev; 2024 Apr; 209():115306. PubMed ID: 38626859
[TBL] [Abstract][Full Text] [Related]
13. Advances in tumor immunomodulation based on nanodrug delivery systems.
Wang B; Zhang Y; Yin X
Front Immunol; 2023; 14():1297493. PubMed ID: 38106403
[TBL] [Abstract][Full Text] [Related]
14. Rational Design of Hyaluronic Acid-Based Copolymer-Mixed Micelle in Combination PD-L1 Immune Checkpoint Blockade for Enhanced Chemo-Immunotherapy of Melanoma.
Zhou C; Dong X; Song C; Cui S; Chen T; Zhang D; Zhao X; Yang C
Front Bioeng Biotechnol; 2021; 9():653417. PubMed ID: 33777920
[TBL] [Abstract][Full Text] [Related]
15.
Qi Z; Pei P; Zhang Y; Chen H; Yang S; Liu T; Zhang Y; Yang K
J Control Release; 2022 Jun; 346():240-249. PubMed ID: 35469982
[TBL] [Abstract][Full Text] [Related]
16. Exploring in vivo combinatorial chemo-immunotherapy: Addressing p97 suppression and immune reinvigoration in pancreatic cancer with tumor microenvironment-responsive nanoformulation.
Lo YL; Li CY; Chou TF; Yang CP; Wu LL; Chen CJ; Chang YH
Biomed Pharmacother; 2024 May; 175():116660. PubMed ID: 38701563
[TBL] [Abstract][Full Text] [Related]
17. Triune Nanomodulator Enables Exhausted Cytotoxic T Lymphocyte Rejuvenation for Cancer Epigenetic Immunotherapy.
Li J; Zhao Q; Zhang N; Wu L; Wang Q; Li J; Pan Q; Pu Y; Luo K; Gu Z; He B
ACS Nano; 2024 May; ():. PubMed ID: 38712706
[TBL] [Abstract][Full Text] [Related]
18. Enzyme/pH Dual-Responsive Engineered Nanoparticles for Improved Tumor Immuno-Chemotherapy.
Liu Z; Hao X; Qian J; Zhang H; Bao H; Yang Q; Gu W; Huang X; Zhang Y
ACS Appl Mater Interfaces; 2024 Mar; 16(10):12951-12964. PubMed ID: 38422377
[TBL] [Abstract][Full Text] [Related]
19. Tumor Microenvironment Cascade-Responsive Nanodrug with Self-Targeting Activation and ROS Regeneration for Synergistic Oxidation-Chemotherapy.
Li Y; Lin J; Wang P; Luo Q; Zhu F; Zhang Y; Hou Z; Liu X; Liu J
Nanomicro Lett; 2020 Sep; 12(1):182. PubMed ID: 34138172
[TBL] [Abstract][Full Text] [Related]
20. Ansamitocin P3-Loaded Gold-NanoCage Conjugated with Immune Checkpoint Inhibitor to Enhance Photo-Chemo-Thermal Maturation of Dendritic Cells for Hepatocellular Carcinoma.
Cheng HW; Ou YL; Kuo CC; Tsao HY; Lu HE
Polymers (Basel); 2021 Aug; 13(16):. PubMed ID: 34451265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
